PEP-Therapy
Jean-Loup Romet Lemonne is on the Board of Directors at PEP-Therapy. Jean-Loup is also a Senior Advisor Global Development at Institut Pasteur, Founder and former CEO of IDM Pharma, Inc. (NASDAQ listed company, now part of Takeda Oncology).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PEP-Therapy
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.